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Patients, who wake up with an ischemic stroke, account for a large number of the total
stroke population, due to circadian morning predominance of stroke. Currently, this sub-
set of patients is excluded from revascularization-therapy since no exact time of onset is
known. A large group of these patients might be eligible for therapy. In this review, we
assessed the current literature about the hypothesis that wake-up-strokes occur just prior
on awakening and if this subgroup differs in characteristics compared to the overall stroke
population. We looked at the safety and efficacy of thrombolysis and interventional tech-
niques in the group of patients with unknown stroke-onset. We performed a meta-analysis
of the diagnostic accuracy of the diffusion-FLAIR mismatch in identifying stroke within 3
and 4.5 h. The different imaging-selection criteria that can be used to treat these patients
are discussed. Additional research on imaging findings associated with recent stroke and
penumbral imaging will eventually lead to a shift from a rigid time-frame based therapy to
a tissue-based individualized treatment approach.
Keywords: wake-up-stroke, unknown-onset stroke, thrombolysis, thrombectomy, circadian rhythm
INTRODUCTION
About one in six persons older than 45 will suffer from stroke in
their remaining lifetime (1). The only Food and Drug Adminis-
tration approved medical therapy for stroke is intravenous tissue
plasminogen activator (alteplase or IV tPA), which should be
administered preferably as quickly as possible within 4 h 30 min
(2). Despite the efficacy of IV tPA, the narrow therapeutic win-
dow precludes wide scale use of the therapy mainly because a large
majority of patients arrive too late in the hospital. Additionally,
observational studies indicate that between 8 and 25% of patients
come to the emergency room with an unknown time of symptom
onset (3–7). This includes patients who were sleeping and woke up
with stroke-symptoms or patients who are unable to state the time
of symptom onset and in whom no witness is available. Theoret-
ically, if patterns on cerebral imaging could serve as a substitute
for the time since the stroke had occurred, then this subset of
stroke patients would not be excluded from thrombolytic therapy.
Another approach could be to rely on the presence of imaging char-
acteristics indicative of large areas of viable tissue, regardless of the
individual’s time since symptom onset, and use this information
to use thrombolysis or other treatment strategies.
A large randomized controlled trial is currently being con-
ducted in Europe to test MRI-based thrombolysis in strokes of
unknown onset (8). The approach is to select patients based on an
imaging pattern that appears to substitute reasonably well for time
since stroke onset, the so-called diffusion/FLAIR (DWI/FLAIR)
mismatch.
Here, we review the literature on “strokes of unknown onset”
or that occur on awakening. We moreover provide a detailed
overview of treatment studies that have already been completed in
wake-up-strokes.
MATERIALS AND METHODS
In this paper, we review the evidence supporting the hypothe-
sis that strokes discovered on awakening are recent. We assess
the current literature on the efficacy and safety of thrombolysis
in wake-up-stroke patients and patients with unknown onset of
stroke. Finally, we review the imaging techniques that are proposed
to determine if a patient with unknown onset of stroke will benefit
from thrombolytic therapy.
A single author searched for articles in the Pubmed and Embase
bibliographic databases using the following search terms: “wake-
up-stroke,”“unknown-onset stroke,”and both these terms with the
additional term ‘treatment,’ “circadian variation and stroke,” and
“diffusion-flair mismatch.” We restricted our search on articles
between 1990 and May 2014. We reviewed articles in the refer-
ence lists of included articles. We restricted our search to articles
published in English. The final reference list was generated on
the basis of relevance to the topics covered in this review. We
performed a meta-analysis of diagnostic studies that assessed the
DWI/FLAIR mismatch pattern in relationship to time since onset
in unselected patients with precisely known symptom onset. We
excluded articles that only focused on posterior circulation stroke
or in whom sensitivity and specificity could not be determined
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from the provided information. Two of the authors (AW,VT) inde-
pendently extracted the number of true positives, false positives,
true negatives, and false negatives within the first 3 h and within
the first 4.5 h after symptom onset of each of the included studies.
Discrepancies between the two authors were resolved by consen-
sus. Data analysis was conducted using the statistical program
Stata (Version 12.0, StataCorp, College Station, TX, USA), and
the user-written command-midas, a module for meta-analytical
integration of diagnostic test accuracy studies (author Ben Dwa-
mena, Division of Nuclear Medicine, Department of Radiology,
University of Michigan Health System, Ann Arbor, USA).
RESULTS
CIRCADIAN VARIATION IN STROKE ONSET
Similar to acute myocardial infarction and sudden cardiac death,
there is a diurnal variation in the onset of stroke, with a higher
frequency of strokes occurring in the morning. The incidence of
early-morning strokes rises with around 50% compared to the
nightly incidence (9). This variation is seen regardless of the type
of stroke (ischemic, hemorrhagic, and transient ischemic attacks)
in some publications (10), but other studies suggest a tendency to
a bimodal curve in hemorrhagic strokes, with a second peak in the
afternoon (11).
The mechanisms underlying this diurnal variation in cere-
brovascular events are not exactly known. Endogenous factors
may play a role in this early-morning dominance in cardiovas-
cular events. An increase in blood pressure, an increase in platelet
aggregation, and a peak in prothrombotic factors are thought to
be contributing factors (12–14). Blood pressure is typically lower
during the night and increases upon awakening (12). This phe-
nomenon is prone to individual variation with some people having
an exaggerated response (15). This so-called “morning surge”
in blood pressure, is an independent risk factor for stroke. It is
speculated that the blood pressure leads to an increase in the like-
lihood of the rupture of a fragile atherosclerotic plaque. Timing
the administration of anti-hypertensive medication in the evening
has been proposed as strategy to circumvent the early-morning rise
(16). A morning increase in platelet aggregation is mainly seen on
arising and standing, and is probably due to an increase in cate-
cholamine levels, platelet count, and hemo-concentration in the
morning (14). An increase in the platelet adhesiveness in morn-
ing hours has been reported instead of increased platelet counts
but this may be caused by different measurement-techniques (17).
Furthermore, Kozinski et al. (18) examined the diurnal effect of
clopidogrel on the inhibition of platelet aggregation. They found
less inhibition in the morning hours. A small study (n= 11)
showed an increase in Lp(a) and fibrinogen, during the morning
hours (19). It is not well understood how these molecules con-
tribute to acute cardiovascular events, apart from their effect on
chronic atherosclerosis. A matutinal endothelial dysfunction has
also been reported. Using high-resolution ultrasound of brachial
artery flow-mediated dilatation, a blunting of endothelial function
in the morning was found (20). Integrity of endothelial function
is important for several homeostatic mechanisms that influence
cardiovascular risk and in this way might contribute to acute cere-
brovascular events. But again, no consistent results were found
(21, 22).
Exogenous factors can play an additional role. The variation
in circulatory factors can be a consequence of an early-morning
response to arousal and physical activity in the awakening state
(23). Data suggest a different response to exercise in the morn-
ing, with a blunting of the normal blood pressure lowering effects
of exercise. Additionally, an association was found between the
very common obstructive sleep apnoe syndrome (OSA) and the
occurrence of wake-up-strokes (24). OSA is associated with inter-
mittent hypoxemia and sympathetic overactivity, which increases
the cardiovascular risk profile and possibly the prevalence of
wake-up-strokes as well (Figure 1).
WAKE-UP-STROKE CHARACTERISTICS
The increase in stroke-occurrence in the morning has implica-
tions for possible treatment of patients with wake-up-stroke. If
most of the strokes detected on awakening indeed occur in the
early-morning hours just prior to awakening, the patients might be
eligible for treatment. A recent epidemiologic study in the United
States (7) found that 35.9% of wake-up-stroke patients would have
been eligible for thrombolysis if arrival time were not a factor. To
confirm or reject the hypothesis that wake-up-strokes occur early
in the morning and have similar characteristics as strokes while
awake, studies have been conducted to explore the possible dif-
ferences between strokes detected on awakening and strokes while
awake. Several studies report that the clinical and imaging charac-
teristics do not differ between these groups (Table 1). One study
(25) looked at the characteristics in terms of clinical impairment,
NIHSS, age, gender, stroke subtype of patients with wake-up-
stroke, and found no difference to a control-group with defined
onset time. Functional outcome also was similar. Another study
compared the clinical and imaging data of patients with known
time of stroke-onset and those with wake-up-strokes, evaluated
within 24 h after the moment, they were last seen normal (3). Both
groups had similar perfusion (PWI) and DWI-lesion volumes on
magnetic resonance imaging and a similarly high percentage of
PWI/DWI mismatch, even in the subgroups of people within 3 h
after detection. A CT-based imaging study (6) found no difference
in percentage of CT perfusion CBF/CBV mismatch in 170 of the
FIGURE 1 | Morning changes in cardiovascular factors contributing to a
higher risk of stroke in the morning hours. Adapted from Ref. (23).
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Table 1 | Clinical characteristic of patients with unknown-onset stroke.
Differences between patients with known and unknown stroke
Authors Total number
of patients (n)
Study set up
and limitations
Wake-up (%)
+ unknown
onset (%)
Clinical characteristics Outcome Imaging
characteristics
Koton et al. (25) 4408 Prospective, consecutive,
hospital based
19 N.s.d. (age, gender, TOAST,
NIHSS)
N.s.d. Not specified
Fink et al. (3) 364 Prospective, consecutive,
hospital based
27 N.s.d. (age, gender, TOAST,
NIHSS)
Not specified DWI/PWI
mismatch
(p=0.4): n.s.d.
Silva et al. (6) 676 Prospective, hospital
based (n=2), consecutive.
Not specified if reader was
blinded, each center had
own reader, time of
detection was randomly
chosen at 7.30 AM
20+18 N.s.d. (age, gender, TOAST,
NIHSS); Unknown-onset
patients were older
(p=0.08), more likely to
be female (p=0.04), and
higher NIHSS (p<0.01)
Not specified CT perfusion
CBF/CBV
mismatch: n.s.d.
Serena et al. (27) 654 Retrospective, hospital
based (n=6), consecutive,
three independent and
blinded readers
24 Nsd. (age, gender, TOAST,
NIHSS, aHT)
Not specified Early signs of
ischemia: n.s.d
(p=0.35)
Todo et al. (26) 81 Retrospective,
consecutive, hospital
based, only
cardioemboligenic strokes,
readers not specified
21+22 N.s.d (age, gender, TOAST,
NIHSS)
Not specified CT: more
hypodens zones
in unknown-onset
group (p>0.001)
Nadeau et al. (5) 2585 Prospective, consecutive,
population based,
informed consent, also
inclusion of hemorrhagic
strokes
13 More smokers
(p=0.0016), high blood
pressure (p=0.0144), and
less tPa (2.1 vs. 13.5%)
Worse outcome:
SIS seven points
lower (p=0.0012)
Not specified
Jimenez et al. (28) 813 Prospective, consecutive,
hospital based
16 More obesity (p=0.058),
less tPa (0 vs. 3%)
Tendency to
worse outcome
(p=0.038)
Not specified
Mackey et al. (7) 1854 Retrospective, hospital
based (n=7)
14.3 N.s.d. (age, gender, TOAST,
NIHSS)
N.s.d. Not specified
N.s.d=no significant difference, TOAST= trial of org 10172 in acute stroke treatment, aHT= arterial hypertension, SIS= stroke impact scale.
evaluated patients. Interestingly, patients with unknown time of
onset occurring outside of awakening were also included, but this
group had more neurological impairment and worse prognosis at
discharge. Another study (26) found similar results with no dif-
ferences in CT-findings between the known onset group and the
wake-up group, but more hypodensities, indicative of later onset,
were found in the unknown-onset group.
In contrast, some studies did report differences between wake-
up strokes and strokes with defined onset. More severe neuro-
logical impairment and a non-significant trend toward worse
functional outcome were observed in one study (28). Worse func-
tional outcome, measured with the stroke impact scale (SIS-16)
and a lower return to home after stroke was reported in a
study that included hemorrhagic strokes. Worse outcomes were
especially observed in subarachnoid hemorrhages occurring on
awakening (5).
Although most studies report similar characteristics between
strokes occurring at wake up and the strokes with a defined onset,
these studies have limitations. Many studies were retrospective (7,
26, 27), single center (3, 25, 26, 28), and not population based (3, 6,
7, 25–28). Studies were heterogeneous in term of study population
with some studies including hemorrhagic strokes (5). The inclu-
sion and exclusion criteria varied across studies. Various imaging
techniques were used and interpretation was not always blinded
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Table 2 | Off-label treatment of patients with unknown-onset stroke.
Authors Design Number of patients
with wake up
or unknown-onset
stroke
control-group
Mean
NIHSS
Mean
age
(years)
Door to
needle
time
(min)
Type of
stroke+ time
from symptom
recognition till
treatment
Imaging criteria Treatment sICH
(%)
mRs
0–1 (%)
mRs
0–2 (%)
Iosif
et al. (30)
Case-report 2 – – – Wake-up DWI/PWI and
DWI/FLAIR
mismatch
Intra-arterial tPa,
thrombectomy
Cho
et al. (31)
Retrospective,
observational
three centers
32
223 (known onset)
14.5 67.5 154 Wake-
up/unknown
onset+3–6 h
DWI/PWI –and
DWI/FLAIR
mismatch+DWI
<1/2 ACM
IV tPa, IV tPa, and
intra-arterial urokinase,
intra-arterial urokinase
6.3 37.5 50
Adams
et al. (32)
AbESTT
Randomized
clinical trial,
>20 centers
22 (treatment)
21 (placebo)
758 (known onset)
10 68.6 ? Wake-up+<3 h NCCT, CT<1/2
ACM
Abciximab 13.6 10 32
Barreto
et al. (4)
Retrospective,
observational,
1 center
46 (treatment)
34 (no treatment)
174 (known onset)
16 (treat-
ment) 10
(no treat-
ment)
62.0 144 Wake-up+no
further time
specification
NCCT, CT>1/3
ACM
IV tPa, IV tPa, and
intra-arterial urokinase,
intra-arterial urokinase
4.3 14 28
Breuer
et al. (33)
Prospective,
1 center
10 (treatment)
35 (no treatment)
10.5 (treat-
ment)
6 (no treat-
ment)
68 80 Wake-up+<6 h MRI visual
PWI/DWI
mismatch, no
FLAIR
hyperintensity, no
DWI>1/3 MCA
IV tPa (0.9 mg/kg) 0 31 60
Kim
et al. (34)
Retrospective,
1 center
29 (treatment)
49 (no treatment)
13 66.9 ? Wake-
up/unknown
onset, <3 h
NCCT, CT<1/3
ACM+Consecutive
PWI before
intra-arterial tPa
IV tPa, IV tPa, and
intra-arterial urokinase,
intra-arterial urokinase
10.3 37.6 44.8
Aoki
et al. (35)
Prospective,
1 center
10 14 84 ? Wake-
up/unknown
onset, <3 h
DWI/FLAIR
mismatch
IV tPa (0.6 mg/kg) 0 30 40
Ebinger
et al. (36)
Observational
substudy,
1 center
17
131 (known onset)
13 81 86 Wake-
up/unknown
onset+<24 h
MRI, DWI<1/3
ACM
IV tPa (0.9 mg/kg) 0 29.4 41.2
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Table 2 | Continued
Authors Design Number of patients
with wake up
or unknown-onset
stroke
control-group
Mean
NIHSS
Mean
age
(years)
Door to
needle
time
(min)
Type of
stroke+ time
from symptom
recognition till
treatment
Imaging criteria Treatment sICH
(%)
mRs
0–1 (%)
mRs
0–2 (%)
Kang
et al. (37)
Prospective, 6
centers
83 (treatment)
156 (no treatment)
14 67.5 155 Wake-
up/unknown
onset+<6 h
DWI/PWI and
DWI/FLAIR
mismatch
DWI<1/3 ACM
IV tPa, IV tPa, and
intra-arterial urokinase,
intra-arterial urokinase
3.6 28.9 44.6
Michel
et al. (38)
Single-center,
prospective,
randomized,
double-
blinded,
placebo-
controlled,
phase II study
6 (treatment)
6 (no treatment)
16 59 122 Wake-
up/unknown
onset+<2 h
CT perfusion (MTT
and CBV)
IV tPa (0.9 mg/kg) 0 ? 4 (66.6)
Manawadu
et al. (39)
Retrospective,
case control,
1 center
68
326 (known onset)
12 74 73 Wake-
up+>4.5 h,
<12 h
NCCT, CT<1/3
ACM
IV tPa (0.9 mg/kg) 2.9 16 37
Bai
et al. (40)
Prispective,
single center
48
138 (known onset)
11 61 ? Wake up+<12 h MRI: DWI/FLAIR
or T2 mismatch.
IV tPa 2 55 ?
Natarajan
et al. (41)
Retrospective,
1 center
30 (wake-up not
specified)
13 72 210 Wake-up/known
onset+8–23 h
CT perfusion,
>30% CBV CT
<1/3 ACM
Intra-arterial thrombolysis,
mechanical thrombectomy,
balloon anioplasty,
intra-arterial
thrombolysis+mechanical
thrombectomy, eptifibatide
33.3 ? 20
Burkart
et al. (42)
Retrospective,
1 center
40 (five unknown
onset)
18 75.4 151 Wake-
up/unknown
onset/known
onset+ timing
not further
specified
Exclusion if
MTT>50% or
NCCT>1/3 ACM
Mechanical thrombectomy
(sometimes with
intra-arterial tPa or IV tPa)
10 ? 50
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or performed by independent observers. Furthermore, publica-
tion bias cannot entirely be excluded, although this is unlikely
since most of the studies are negative (i.e., showing no difference).
Further, prospective, population based, multicenter studies,
using strictly defined inclusion criteria, employing standardized
imaging with blind evaluation are therefore warranted.
MEDICAL AND INTERVENTIONAL THERAPY FOR PATIENTS WITH
UNKNOWN TIME OF STROKE-ONSET: CURRENT EVIDENCE
We identified 12 studies in which wake-up-stroke-patients (WUS)
were treated with intravenous tPA, either with or without intra-
arterial therapy (Table 2). In 2006 (29) and 2008 (30) already, two
case-reports were published about thrombolysis and mechanical
reperfusion of patients with unknown stroke-onset. They sug-
gested an imaging-based selection to define which patients would
benefit from thrombolysis regardless of the time of stroke-onset.
THROMBOLYSIS
Subsequent studies compared outcome after treatment of known-
and unknown-onset ischemic stroke. One of the first was a ret-
rospective study among three centers, which included 32 patients
with unknown-onset stroke and 223 controls (31). There was no
difference in the outcomes of the two groups. The limitations of
this retrospective study include the small number of patients and
the imbalance in treatment methods among the two groups with
more use of intra-arterial thrombolysis in the unknown-onset
group. Images were not analyzed uniformly and like in most of the
current studies,only one reader was used to interpret the images. In
the AbESTT-trial (32) abciximab, a GPIIbIIIb receptor blocker was
tested in a randomized controlled trial as a potential treatment of
acute ischemic stroke. A subgroup of WUS patients who presented
within 3 h after symptom recognition was also included. Unfortu-
nately inclusion of this subgroup was stopped early, because of an
unacceptably high rate of symptomatic intracranial hemorrhages
(SICH). In the end, it was shown that abciximab did not improve
outcome overall. WUS patients in this study exhibited significantly
more signs of early ischemia on CT compared to the non-wake-
up group, suggesting that these patients did not have very early
stroke and had less chance to respond to reperfusion-therapies.
Barreto et al. (4) retrospectively compared the outcomes of wake-
up patients who were treated with intravenous tPA, intra-arterial
urokinase or a combination of both, and those who did not. Non-
contrast CT was used to exclude a hypodensity larger than 1/3
of the middle cerebral artery territory. Multimodal neuroimaging
was not a part of their study-protocol. Despite a greater clinical
impairment, they found a higher rate of good outcomes in the
treated patients, however, at the expense of an increased mortality.
Additionally, a comparison was made between wake-up-strokes
and patients with known onset time who received thromboly-
sis within 3 h of symptom onset. Having adjusted for baseline
differences in NIHSS, outcomes were similar. This retrospective
study is limited by its lack of clinical or imaging selection cri-
teria, the various treatment modalities, a possible selection bias
and the relatively small sample size. In a similar study, throm-
bolysis in wake-up patients was significantly associated with a
favorable outcome at 3 months (odds ratio= 6.842) (34). When a
large diffusion-deficit on MRI was found, tPA-administration was
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Table 3 | Characteristics of the proposed imaging-modalities.
Advantages Disadvantages
CT perfusion • Widely available at ER
• Fast
• Low cost
• Easy patient monitoring
• Helps to identify patients who would benefit from therapy
and those with high hemorrhagic risk
• Additional radiation dose
• IV contrast
• Difficult to detect small infarcts
• Protocols and guidelines for quantitative thresholds vary
• Different post-processing programs
• AIF (arterial input function) and VOF (venous input
function) difficult to localize
• False positive results: Decreased blood flow due to
vascular stenosis, extensive white matter disease, seizure
and vasospasm
• False negative results: partial volume effect around blood
vessels
MRI perfusion • High sensitivity and high predictive value for ischemia
• Increasing evidence that ADC can reliable predict
ischemic core
• PWI/DWI mismatch for selection of patients who would
benefit from therapy and those with high hemorrhagic risk
(malignant profile)
• Duration of scan
• Limited availability
• Use of a contrast agent
• Limitations: pacemakers, claustrophobia
• Monitoring of patients is more difficult
• Protocols and guidelines for quantitative thresholds vary
• Different post-processing programs
DWI/FLAIR mismatch • Imaging marker for timing of stroke-onset based on
pathophysiologic tissue changes in the evolution of acute
stroke
• Qualitative assessment→no need for long
postprocessing
• Validation in large PRE-FLAIR study
• Relative high interrater- and intrarater-variability
• Sensitivity is quite low→ stroke-patients within
time-interval to benefit from tPA can be missed
stopped. This happened in 5 out of the 22 cases at various time
points after tPA infusion started. This increased the heterogene-
ity in the study population and highlights the need for uniform
pre-treatment imaging selection criteria. A small study (n= 10),
without a control-group, showed a safe selection of patients based
on DWI/FLAIR mismatch with no SICH occurring (35). However,
the sample size was obviously small and a lower than currently
accepted dose of tPA (0.6 mg/kg) was used. Also the time from last
seen well till treatment was on average 5.6 h, which is lower than
in most other studies. A similar observational study reported no
SICH and no difference in outcome in 17 similarly selected patients
(36). The study of Kang et al. (37) had multiple advantages over
the previous ones. A large group of patients with unknown-onset
time of stroke (n= 83) were included and they used well-defined
clinical and imaging selection criteria. Only WUS-patients were
treated who both had a DWI/PWI and a DWI/FLAIR mismatch.
After adjusting for age, sex, and baseline NIHSS score, reperfu-
sion therapy significantly increased the incidence of good clinical
outcomes in unclear-onset stroke patients compared to a matched-
cohort of untreated patients (odds ratio, 2.25). However, although
the clinical inclusion criteria were similar, the control patients
did not undergo the same stringent imaging selection criterion,
which biases the findings of this study. Other limitations were the
participation of two centers with no previous experience in MRI-
based thrombolysis studies. Only 1 of the 10 patients treated in
these centers, did have a good outcome. Although they used two
MRI-based selection criteria, no pre-trial training was foreseen.
Organization of a training course in advance could have increased
the reproducibility of the image protocols.
MECHANICAL THROMBECTOMY
Four studies [(41–44); Table 2] examined the possible bene-
fit of mechanical thrombectomy, all based on perfusion (CT
or MRI) scans and clinical criteria to include patients. One
study (43) included 19 patients with wake-up-strokes. They used
stent-retriever-devices for mechanical thrombectomy. Compared
to other studies with known onset stroke, a larger number of
SICH were found and patients had less favorable outcome after
3 months. Another study (44) found no significant difference in
outcome between known and unknown-onset stroke patients.
However, selection of patients was based on individual decision
making and various treatment techniques were used over the years.
SUMMARY
From these pilot-studies, we conclude that many patients
with wake-up or unknown-onset stroke might be helped by
revascularization-therapy with relative safety. There is more expe-
rience with intravenous treatment than with endovascular thera-
pies. Limitations in using clinical databases are the possible bias
in selection of patients, completeness of data, and retrospective
determination of outcome. Moreover, publication bias cannot be
excluded, as there are no small studies published, which show
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unfavorable results. Only two studies (32, 38) testing thromboly-
sis or thrombectomy were randomized. One was the AbESTT-trial
(32), discussed previously and the other one was a small pilot-
study with only 12 patients included (38). The imaging selection
criteria used to select patients for treatment were not uniform,
since most centers used individual decision making to treat this
subset of patients. A large clinical randomized trial is therefore
needed to confirm these preliminary results.
PROPOSED IMAGING SELECTION METHODS
Unknown time of onset is clearly a major reason not to receive
thrombolysis (45). In the studies with off-label treatment of
unknown-onset stroke patients, different imaging selection cri-
teria have been used [Table 2; (46)]. These include visual or
semi-quantitative analysis of the FLAIR-DWI mismatch, PWI-
DWI mismatch, or CT perfusion based approaches (Table 3;
Figure 2).
DWI-FLAIR MISMATCH
Several groups used the presence of a DWI/FLAIR mismatch to
guide thrombolysis in patients with unknown-onset stroke (33, 35,
37, 40). The idea behind the FLAIR-DWI mismatch analysis prin-
ciple is based on the pathophysiology of acute cerebral ischemia.
Diffusion-weighted imaging is most sensitive to a restriction of
the Brownian motion of extracellular water caused by cytotoxic
edema. This phenomenon is already present within minutes after
FIGURE 2 |The different imaging techniques used to select
stroke-patients who would benefit from therapy. Patient 1 exhibits no
FLAIR-lesion (A) and a clear DWI-lesion (B), the so-called DWI-FLAIR
mismatch pattern. Patient 2 has a PWI/DWI mismatch on imaging, with (C)
representing the lesion onTmax, and (D) the corresponding diffusion lesion.
the event. FLAIR-images are sensitive for the detection of vaso-
genic edema, a phenomenon, which starts gradually in the hours
after the initial event. This edema is thought to reflect loss of the
integrity of the blood brain barrier.
A large multicenter observational study showed that the pattern
of an acute ischemic lesion seen with DWI but not with FLAIR-
imaging, decreases with longer time between onset of symptoms
and MRI scanning (47). DWI/FLAIR mismatch had a sensitivity of
62%, a specificity of 78%, and a positive likelihood ratio of 3.6, for
the detection of stroke patients within 4.5 h of stroke onset. In that
study, a visual analysis was used that required complete absence of
even subtle FLAIR lesions. In a later substudy (48), a more liberal
visual rating system was used, in which subtle FLAIR lesions were
still considered as DWI/FLAIR mismatch. This improved the sen-
sitivity (0.86), but decreased the specificity (0.48) of this pattern
to detect lesions within 4.5 h. The positive likelihood ratio for the
liberal rating system was 2.6. The disadvantage of the liberal rat-
ing system is an increase in the interrater-variability for “subtle”
FLAIR lesions. Figure 3 shows a meta-analysis of reported diag-
nostic studies that assessed the DWI/FLAIR mismatch pattern in
relationship to time since onset in patients with precisely known
symptom onset. The overall sensitivity of the DWI/FLAIR mis-
match for detecting stroke within 3 h is 74% and within 4.5 h is
62%, with a specificity of 82% at both time points. The diagnos-
tic accuracy is quite heterogeneous and may reflect differences in
inclusion criteria, definitions of FLAIR/DWI mismatch, acquisi-
tion techniques, proportions of small, and infratentorial lesions
between the studies.
Semi-quantitative analysis of the FLAIR signal intensities has
been proposed in order to avoid interpretation issues (53). How-
ever, this is controversial and in the PRE-FLAIR study an improve-
ment over quantitative analysis of FLAIR signal was not better
than visual analysis (48, 54). It has been shown that a significant
amount of wake-up-stroke patients has such a DWI/FLAIR mis-
match pattern (55). There are limitations though of the sole use
of DWI/FLAIR mismatch to select patients for therapy. First there
is no certainty about which technique (liberal or strict) has to be
used to visually assess the presence of a DWI/FLAIR mismatch.
Second, because of the low sensitivity, a large amount of possible
eligible patients will be excluded from therapy. The interpreta-
tion of the mismatch pattern also depends on the type of stroke.
With every 10 ml increase in diffusion volume, the odds to find a
flair positive lesion increases with 7% (47). For patients with an
infratentorial stroke, the DWI/FLAIR mismatch pattern seems to
be less robust in identifying patients with early onset (56). The
risk of bleeding in patients with a DWI/FLAIR mismatch is still
uncertain. One recent study suggests a higher risk of bleeding with
early FLAIR-hyperintensity (57), while another study found no
association (58). Flair-positivity might be associated with a worse
outcome after 3 months,but this finding still needs to be confirmed
(59). Other imaging parameters have to be found to make a more
optimal selection of patients who would benefit from therapy.
CT PERFUSION
Another approach is to select patients based on the presence
of imaging markers of tissue at risk or other imaging charac-
teristics. CT combined with perfusion CT is a widely available
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A
B
FIGURE 3 | Meta-analysis (47, 49–52) of the “strict” DWI/FLAIR mismatch
pattern predicting stroke onset before 3 and 4 h. (A) shows the sensitivity
and specificity for predicting stroke-onset before 3 h and (B) shows these
values for stroke-onset before 4.5 h. *To predict stroke onset before 4.5 h the
“liberal” method of DWI/FLAIR mismatch was used in the study of Petkova
et al. (49).
technique that may help decide if patients with unknown-onset
stroke, are eligible for off-label use of thrombolysis (29, 38, 41).
Different hemodynamic parameters like cerebral blood volume
(CBV), cerebral blood flow (CBF), delay time (Tmax), and mean
transit time (MTT) have been proposed to identify areas of critical
hypoperfusion. The ischemic core is variously defined as a region
with markedly reduced CBV or CBF combined with prolonged
MTT or Tmax. However, a real consensus on which parameter
and threshold best represents critical hypoperfusion and core has
not emerged yet. Different definitions with different thresholds
have been proposed to define the tissue at risk. Wintermark et al.
(60) did a ROC analysis and proposed an optimal threshold of
2 ml/100 g for CBV to define the ischemic core and 145% of MTT
to define the tissue at risk of infarction. More recent evidence
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suggests that relative CBF might be better to define infarct core
then CBV (61, 62). The more recent literature suggests a threshold
of CT-Tmax of >6 s to define the tissue at risk (63). Despite that
no real consensus exists about the thresholds that should be used,
the speed and wide availability make perfusion CT an interesting
alternative compared to other perfusion-modalities.
PWI/DWI MISMATCH
Perfusion and diffusion based MR imaging techniques have been
advocated as an imaging selection method in wake-up strokes
(Figure 2). The disadvantage of the latter technique is the longer
imaging time required and the limited availability of MRI com-
pared to CT. Dynamic susceptibility contrast enhanced MRI is
the most widely used technique. Arterial spin labeling is a newer
method and has no need for contrast, but requires, in general,
longer imaging times. MRI does have the advantage of a reliable
prediction of the ischemic core with ADC-maps (64). However,
the possible reversibility of the diffusion lesion, questions the
paradigm that diffusion lesions represent the ischemic core. Analy-
sis of the EPITHET-data showed that true DWI-lesion reversal
is uncommon and if present would rarely alter treatment deci-
sion making (65). As with CT, difficulties arise in determining the
optimal thresholds to differentiate ischemic core from salvageable
brain tissue (66). Also the selection of the most optimal parame-
ter or combination of parameters is still a matter of debate (67).
An ADC-threshold of 600× 10−6 mm2/s seems a fairly robust
parameter in predicting ischemic core tissue (64). The mismatch
between an area that has a Tmax> 6 s and is below this ADC-
threshold is currently considered in several clinical trials as an
operational definition of the tissue at risk. A substudy of DEFUSE
2 (68) supported this hypothesis by showing that in patients with
a strong reperfusion, there is a high correlation between base-
line DWI-volume and final infarct and in patients with minimal
or no reperfusion, there is a high correlation between the base-
line PWI-volume and final infarct. To determine the tissue at
risk the PWI-DWI mismatch is useful, with 120% most com-
monly used to define a mismatch, although more stringent criteria
have been advocated, with studies now advocating a perfusion-
diffusion ratio that is larger than 180%, dependent on the para-
meter that is used to define the perfusion abnormality. MRI can
also detect the so-called “ malignant” profile. The DEFUSE-data
(69) showed that patients with a baseline DWI-lesion bigger than
100 ml and/or a PWI lesion of 100 ml or more with 8 s or longer
of Tmax delay, suffered more intracranial hemorrhages after early
reperfusion. The major drawback in the clinical use of MRI per-
fusion is that the extent of perfusion abnormalities varies among
perfusion parameters, software packages, and various algorithms
and that upon today no consensus is reached. Other techniques
to define tissue at risk, like FDG-PET or SPECT, are less eas-
ily used in clinical practice. Two large trials to treat wake-up
patients are currently ongoing, one based on DWI/FLAIR mis-
match (WAKE-UP) (8) and one based on penumbral imaging
(EXTEND) (70).
CONCLUSION
Wake-up-stroke and stroke with unknown time of onset are fre-
quent. These patients are at present excluded from thrombolytic
therapy. Evidence suggests that these strokes occur closely on
awakening and most observational studies did not find differences
in terms of clinical features or outcome after therapy, suggesting
that at least a subset of these patients could benefit of throm-
bolysis or endovascular treatment. Selection of eligible patients
is preferably done using neuro-imaging, but the optimal imag-
ing selection strategy for treating these patients has not yet been
defined. The proposed selection modalities have not been properly
evaluated in randomized trials, therefore, inclusion in these trials
is primordial. In case randomization is not possible, advocating
treatment on the basis of the presence of a DWI/FLAIR mismatch
or PWI/DWI mismatch can generally not be recommended. In
this scenario, treatment must remain an individualized decision.
Ongoing randomized controlled trials testing these strategies are
the WAKE-UP trial (8) and the EXTEND-trial (70). Identifying a
safe and efficacious selection strategy will not only benefit patients
with WUS, but also allow moving away from a rigid time window
based approach for all patients.
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